← Back to Search

People infected with related NTM isolates identified as having membership in a related cluster for Tuberculosis (C Trial)

N/A
Recruiting
Research Sponsored by National Jewish Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male or female participant of any age who has a history of NTM or a first positive NTM culture collected as part of routine clinical care from expectorated sputum, induced sputum and/or bronchoalveolar lavage.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

C Trial Summary

The goal of this observational study is to facilitate standardized nontuberculous mycobacteria (NTM) outbreak investigations in healthcare centers. The main questions it aims to answer are: Are respiratory NTM isolates identified as having membership in a suspected healthcare outbreak highly related based on whole genome sequencing? Does epidemiologic investigation support healthcare-associated patient-to-patient NTM transmission? Does healthcare environmental sampling support healthcare-associated NTM acquisition? If healthcare-associated NTM outbreaks are suspected, participants identified as having membership in a cluster of highly-related NTM infections will complete a demographic questionnaire.

Eligible Conditions
  • Nontuberculous Mycobacterial Lung Disease
  • Tuberculosis
  • Healthcare-Associated Infections
  • Outbreak Investigation

C Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

C Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dust and Water Biofilm Collection
Home of Residence Watershed Mapping
Secondary outcome measures
Epidemiologic Investigation
Healthcare Environment Dust and Water Biofilm Collection

C Trial Design

1Treatment groups
Experimental Treatment
Group I: People infected with related NTM isolates identified as having membership in a related clusterExperimental Treatment1 Intervention
Characterize the source(s) of acquisition and/or direct or indirect patient-to-patient transmission of NTM within a healthcare setting among participants with highly related isolates.

Find a Location

Who is running the clinical trial?

National Jewish HealthLead Sponsor
140 Previous Clinical Trials
316,136 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
2023. "Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06155747.
All > Denver > Colorado Springs
~48 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top